DynaLynk Pharma is the latest high-tech investment undertaken by local pharmaceutical company Lynk Biotechnologies, further expanding the Lynk Group’s competencies from its traditional domains of R&D and product development into the pharmaceutical manufacturing arena. DynaLynk Pharma lends manufacturing capability to the Group’s thrust in commercialising locally-generated intellectual property, enabling the Group to meet business growth needs worldwide.
DynaLynk Pharma’s rigorous quality systems, state-of-the-art equipment and
facilities, as well as a commitment to excellence place it in a prime position
to offer its valued partners reliable, responsive and specialised contract
manufacturing solutions.
Please visit www.dynalynkpharma.com for more information.